ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.72 USD | -1.14% |
|
-0.76% | -18.22% |
| 17/07 | RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276 | MT |
| 15/07 | Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating | MT |
| Market Cap | 2.87TCr 2.51TCr 2.31TCr 2.13TCr 4.02TCr 2,76400Cr 4.11TCr 28TCr 11TCr 1,35400Cr 11TCr 11TCr 4,66000Cr | P/E 2026 * |
18.8x | P/E 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 2.79TCr 2.44TCr 2.25TCr 2.08TCr 3.91TCr 2,68900Cr 4TCr 27TCr 11TCr 1,31700Cr 10TCr 10TCr 4,53300Cr | EV / Sales 2026 * |
4.94x | EV / Sales 2027 * | 4.57x |
| Free-Float |
75.61% | Yield 2026 * |
1.22% | Yield 2027 * | 1.32% |
Last Transcript: ResMed, Inc.
| 1 day | -0.87% | ||
| 1 week | -0.74% | ||
| Current month | +1.10% | ||
| 1 month | +4.55% | ||
| 3 months | -12.87% | ||
| 6 months | -22.18% | ||
| Current year | -18.20% |
| 1 week | 190.76 |  | 203.88 |
| 1 month | 187.24 | | 222.43 |
| Current year | 180.26 | | 277.67 |
| 1 year | 180.26 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 56.59 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/07/26 | Fiscal year | Chief Executive Officer | 14,973 | 0.0103% | ||
| 08/06/26 | Fiscal year | Chief Executive Officer | 14,973 | 0.0103% | ||
| 01/06/26 | Tax | General Counsel | -269 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | -0.74% | -24.53% | -10.15% | 2.87TCr | |
| -1.18% | -0.40% | +29.99% | -2.21% | 20TCr | |
| -0.97% | +0.96% | +7.45% | -17.31% | 14TCr | |
| +1.69% | -13.88% | -32.07% | +0.85% | 12TCr | |
| +0.40% | -1.04% | -57.42% | -17.35% | 6.54TCr | |
| -0.09% | -6.70% | +11.86% | -7.57% | 4.94TCr | |
| +0.65% | -0.59% | -22.82% | -31.15% | 4.47TCr | |
| +0.28% | -1.05% | +18.38% | +6.49% | 3.71TCr | |
| -2.44% | -3.62% | +27.71% | +28.57% | 3.62TCr | |
| +0.17% | -3.71% | -15.20% | -23.16% | 2.87TCr | |
| Average | -0.34% | -2.78% | -5.66% | -7.30% | 7.55TCr | |
| Weighted average by Cap. | -0.41% | -2.61% | -0.74% | -7.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 564.98Cr 493.73Cr 455.6Cr 419.95Cr 791.53Cr 54TCr 809.11Cr 5.45TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr | 596.1Cr 520.93Cr 480.7Cr 443.09Cr 835.14Cr 57TCr 853.68Cr 5.75TCr 2.26TCr 28TCr 2.24TCr 2.19TCr 97TCr |
| Net income | 154.53Cr 135.04Cr 124.61Cr 114.86Cr 216.5Cr 15TCr 221.3Cr 1.49TCr 585.84Cr 7.29TCr 580.34Cr 567.6Cr 25TCr | 161.96Cr 141.54Cr 130.61Cr 120.39Cr 226.91Cr 16TCr 231.95Cr 1.56TCr 614.02Cr 7.64TCr 608.25Cr 594.91Cr 26TCr |
| Net Debt | -78Cr -68Cr -63Cr -58Cr -109.73Cr -7.54TCr -112.17Cr -754.96Cr -296.94Cr -3.69TCr -294.15Cr -287.7Cr -13TCr | -145.68Cr -127.31Cr -117.48Cr -108.29Cr -204.1Cr -14TCr -208.64Cr -1.4TCr -552.31Cr -6.87TCr -547.12Cr -535.12Cr -24TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $196.99 | -1.01% | 2,62,783 |
| 17/26/17 | $198.99 | -1.86% | 12,84,198 |
| 16/26/16 | $202.76 | +2.11% | 10,19,540 |
| 15/26/15 | $198.57 | +2.88% | 12,08,785 |
| 14/26/14 | $193.01 | -2.77% | 16,22,359 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
